surmount-1 tirzepatide trial weight loss non-diabetic once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 surmount-1 trial tirzepatide non-diabetic weight
Pay in 4 interest-free payments of $6.70 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22








:max_bytes(150000):strip_icc():focal(745x164:747x166)/Ozempic-costco-040324-tout-9c37daf8c3eb4ae5936e85c87b840495.jpg)












